PIGW

Phosphatidylinositol glycan anchor biosynthesis class W Q7Z7B1 PIGW_HUMAN
Protein Coding Chr 17 17q12 Swiss-Prot reviewed Entrez 284098
Mutations
40
CL 24 · Tissue 0
Samples
27
CL 21 · Tissue 0
Peptides
40
unique mutant peptides
Transcripts
1
isoforms mutated

Stats by Source

Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)

How the counts split by source
Stats by Source

Total = all mutations for this gene across every source.

Cell line = COSMIC Cell Lines Project + DepMap + PubMed.

Tissue = COSMIC primary-tissue (patient tumour) samples.

Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.

TotalCell lineTissue
Mutations40240
Samples27210
Peptides40240

Function

PIGW · Phosphatidylinositol glycan anchor biosynthesis class W

The protein encoded by this gene is an inositol acyltransferase that acylates the inositol ring of phosphatidylinositol. This occurs in the endoplasmic reticulum and is a step in the biosynthesis of glycosylphosphatidylinositol (GPI), which anchors many cell surface proteins to the membrane. Defects in this gene are a cause of the age-dependent epileptic encephalopathy West syndrome as well as a syndrome exhibiting hyperphosphatasia and cognitive disability (HPMRS5). [provided by RefSeq, Jul 2017].

Isoforms & Proteins

1 transcript · UniProt mapping is sequence-verified (AA-safe)

About the isoform mapping
Isoforms & Proteins

Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.

The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.

Counts are mutations and unique mutant peptides on each transcript.

TranscriptUniProtMutationsPeptides
ENST00000614443 Q7Z7B1 40 40

Gene Properties

Type
Protein Coding
Chromosome
17
Cytoband
17q12
Entrez ID
Aliases
Gwt1HPMRS5

Recurrent Mutations

All 40 amino-acid changes on canonical ENST00000614443 · needle height = samples · drag the mini-map to zoom

What this lollipop shows
Recurrent Mutations

A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).

X-axis = amino-acid position in the protein.

Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.

The most recurrent changes are labelled; hover any needle for the change, position and counts.

Mutation frequency across cancer types

% of samples with a missense/complex mutation in PIGW · cell line vs tissue

How this frequency is counted
Cancer-type mutation frequency

For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in PIGW – counted as distinct samples (a sample counts once no matter how many mutations it has).

Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.

Cancer typeCell linesTissue samples
T-Cell Non-Hodgkins Lymphoma
1/26 4%
0/0 0%
Glioblastoma
1/98 1%
0/0 0%
Endometrial Carcinoma
4/42 10%
1/612 0%
Neuroendocrine Tumour
2/154 1%
0/577 0%
Melanoma
3/210 1%
1/1899 0%
Non-Small Cell Lung Carcinoma
1/304 0%
1/1390 0%
Gastric Carcinoma
1/74 1%
1/1809 0%
Kidney Carcinoma
2/85 2%
0/1862 0%
Colorectal Carcinoma
3/143 2%
0/3239 0%
Thyroid Gland Carcinoma
1/45 2%
0/1592 0%
B-Cell Non-Hodgkins Lymphoma
1/88 1%
0/2534 0%
Hepatocellular Carcinoma
0/46 0%
1/2210 0%
Other Blood Cancers
1/61 2%
0/2725 0%
Breast Carcinoma
0/144 0%
1/3264 0%

Mutation Distribution

Where PIGW is mutated · all tissues, split by cell line vs tissue

Mutation counts by tissue
Mutation Distribution

How many mutations in PIGW were found in each tissue, across the whole database.

Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.

This shows the cancer-context where this gene is recurrently altered.

GTEx Expression

Median TPM across 54 healthy tissues

GTEx Portal ↗
About the expression data
GTEx Expression

Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.

Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.

Scroll or drag the mini-axis below the chart to browse all tissues.

Mutations

All 40 mutations in PIGW

About the mutation list
Mutations

Every mutation record for this gene, across all samples and sources.

The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).

Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.

IDSampleTranscriptAA Change CDSTypeSourceMutant PeptideWild-type Peptide